Abstract
The E-value 1 is a relatively new metric for assessing the sensitivity or robustness of associations to potential unmeasured confounding. In a recent exchange in the International Journal of Epidemiology, a series of commentaries 1–7 were written in response to a paper by Blum et al. 8 That paper provided insightful descriptive analyses of the early uses of the E-value. Although the commentary invitations arose from the Blum et al. paper, 7 many of the resulting commentaries were directed principally at the E-value itself; the entire set served as a tribunal of sorts on the nature and usefulness of the E-value. Several of the commentaries provided what I thought were balanced appraisals of the E-value, noting both its uses and limitations and the need to often supplement or replace the E-value with more extensive sensitivity analysis. I was very sympathetic to the positions put forward by Groenwold, 3 Kaufman, 4 and Fox et al. 5
Funding Information
  • NIH (R01CA222147)

This publication has 29 references indexed in Scilit: